{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:58:02Z","timestamp":1783569482657,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.brachy.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T00:46:51Z","timestamp":1512175611000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy"],"prefix":"10.1016","volume":"17","author":[{"given":"Susan Y.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Boreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey P.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Adam M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuto","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.10.014_bib1","unstructured":"SEER Cancer Statistics Review, 1975-2013, National Cancer Institute."},{"key":"10.1016\/j.brachy.2017.10.014_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jrr\/rrt027","article-title":"The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer","volume":"54","author":"Yoshioka","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2017.10.014_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.brachy.2014.03.002","article-title":"High-dose-rate brachytherapy as monotherapy for prostate cancer","volume":"13","author":"Demanes","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brachy.2013.05.004","article-title":"Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients","volume":"13","author":"Marina","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2005.06.154","article-title":"Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate","volume":"23","author":"Sathya","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib9","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1016\/j.ijrobp.2015.07.1038","article-title":"Low-dose-rate prostate brachytherapy is superior to dose-escalated EBRT for unfavorable risk prostate cancer: the results of the ASCENDE-RT randomized control trial","volume":"93","author":"Rodda","year":"2015","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.brachy.2017.10.014_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.radonc.2013.09.025","article-title":"High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity","volume":"110","author":"Hoskin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijrobp.2009.05.054","article-title":"Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life","volume":"77","author":"Morton","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5114\/jcb.2016.59216","article-title":"Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results","volume":"2","author":"Lauche","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib13","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cncr.22934","article-title":"Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2017.10.014_bib14","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.clon.2016.05.005","article-title":"SpaceOAR hydrogel in dose-escalated prostate cancer radiotherapy: rectal dosimetry and late toxicity","volume":"28","author":"Whalley","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib15","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1016\/j.ijrobp.2009.07.688","article-title":"Dose-volume analysis of predictors for chronic rectal toxicity following treatment of prostate cancer with adaptive image-guided radiotherapy (IGRT)","volume":"75","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brachy.2015.12.007","article-title":"Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy","volume":"15","author":"Yeh","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijrobp.2012.12.019","article-title":"A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes","volume":"87","author":"Song","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib19","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1111\/j.1464-410X.2012.11373.x","article-title":"Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy","volume":"110","author":"Hatiboglu","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2017.10.014_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2004.05.007","article-title":"Comparison of inverse planning simulated annealing and geometrical optimization for\u00a0prostate high-dose-rate brachytherapy","volume":"3","author":"Hsu","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1118\/1.1368127","article-title":"Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function","volume":"28","author":"Lessard","year":"2001","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.brachy.2011.07.009","article-title":"Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose\u00a0plans using inverse planning simulated annealing for prostate\u00a0high-dose-rate brachytherapy","volume":"11","author":"Cunha","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prro.2013.02.011","article-title":"Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose","volume":"4","author":"Hsu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.08.048","article-title":"Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321","volume":"78","author":"Hsu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5114\/jcb.2015.48838","article-title":"High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer","volume":"1","author":"Cendales","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.014_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2010.10.015","article-title":"High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer","volume":"81","author":"Demanes","year":"2011","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.brachy.2017.10.014_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2014.02.011","article-title":"A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy\u00b1intensity modulated radiation therapy","volume":"111","author":"Strom","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2015.01.005","article-title":"Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective?","volume":"114","author":"Vanneste","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib29","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ijrobp.2011.03.028","article-title":"Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome","volume":"82","author":"Valdagni","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0360-3016(02)02857-2","article-title":"High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients","volume":"53","author":"Zelefsky","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib31","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.ijrobp.2014.05.1292","article-title":"A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose-rate brachytherapy \u00b1 intensity modulated radiation therapy","volume":"90","author":"Strom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.014_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-13-27","article-title":"Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity- modulated radiotherapy for clinically localized prostate cancer","volume":"13","author":"Eckert","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2017.10.014_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/raon-2016-0036","article-title":"Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients","volume":"50","author":"M\u00fcller","year":"2016","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.brachy.2017.10.014_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1748-717X-9-96","article-title":"Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial","volume":"9","author":"Uhl","year":"2014","journal-title":"Radiat Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:12:05Z","timestamp":1761531125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117304890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1538472117304890"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.10.014","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}